Clinical trial
Impact of the Daily Doxycycline Pre-exposure Prophylaxis (PrEP) on the Incidence of Syphilis, Gonorrhoea and Chlamydia
NCT03709459 is registered in ClinicalTrials.gov with Kirby Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of the Daily Doxycycline Pre-exposure Prophylaxis (PrEP) on the Incidence of Syphilis, Gonorrhoea and Chlamydia
- Lead sponsor
- Kirby Institute
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- December 17, 2019
- Completion date
- December 17, 2024
- Enrollment
- 100 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
stis prevention